News
- Ibogaine
- Ketamine
- LSD
- MDMA
- Psilocybin
Resources
Opinion
Events
About Us

MDMA

MDMA

Lykos Therapeutics Shakeup Continues With Leadership Change

September 6, 2024

Lykos Therapeutics Slashes Workforce, Reshuffles Leadership After FDA Rejection

August 22, 2024

MDMA for PTSD: Setback Sparks New Battle Plan

August 14, 2024

Fluence, Enthea Partner to Expand Access for Ketamine-Assisted Therapy

July 7, 2024

Analysis: MDMA Setback Shows Psychedelic Medicine Still Has Work Ahead

June 7, 2024

Optimi Health Receives Regulatory Approval to Export to Australia

June 3, 2024

Lykos Appoints Finance Veteran Scott Giacobello to Board of Directors

May 31, 2024

Concerns Raised About MDMA-Assisted Psychotherapy Trials for PTSD

May 17, 2024

Lykos Therapeutics: FDA Set to Review MDMA for PTSD Treatment

May 9, 2024

Horizons: Perspectives on Psychedelics Conference Convenes in New York City

May 7, 2024

Lykos Adds to Executive Team as it Ramps for Potential Launch of MDMA-Assisted Therapy

May 6, 2024

Preserving a Legacy: Wendy Tucker’s Vision for Shulgin Farm

April 26, 2024

Home
News
Resources
Opinion
Events
About Us

Contact Us

Name *

Email *

Subject *

Message